Christian Lienhardt de 2001 à 2022 dans la base Horizon  

2022

Articles référencés dans le Web of Science


  1. Nsengiyumva N. P., Campbell J. R., Oxlade O., Vesga J. F., Lienhardt Christian, Trajman A., Falzon D., Den Boon S., Arinaminpathy N., Schwartzman K. (2022). Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa : an analysis of costs and cost-effectiveness. PLoS Medicine, 19 (6), p. e1004032 [17 p.]. ISSN 1549-1277.
    Identifiant IRD :  fdi:010085875

  2. Den Boon S., Lienhardt Christian, Zignol M., Schwartzman K., Arinaminpathy N., Campbell J. R., Nahid P., Penazzato M., Menzies D., Vesga J. F., Oxlade O., Churchyard G., Merle C. S., Kasaeva T., Falzon D. (2022). WHO target product profiles for TB preventive treatment. International Journal of Tuberculosis and Lung Disease, 26 (4), p. 302-309. ISSN 1027-3719.
    Identifiant IRD :  fdi:010085929

  3. Vesga J. F., Lienhardt Christian, Nsengiyumva P., Campbell J. R., Oxlade O., den Boon S., Falzon D., Schwartzman K., Churchyard G., Arinaminpathy N. (2022). Prioritising attributes for tuberculosis preventive treatment regimens : a modelling analysis. BMC Medicine, 20 (1), p. 182 [12 p.]. ISSN 1741-7015.
    Identifiant IRD :  fdi:010085140

  4. Butler M. S., Gigante V., Sati H., Paulin S., Al-Sulaiman L., Rex J. H., Fernandes P., Arias C. A., Paul M., Thwaites G. E., Czaplewski L., Alm R. A., Lienhardt Christian, Spigelman M., Silver L. L., Ohmagari N., Kozlov R., Harbarth S., Beyer P. (2022). Reply to Kaye and Belley, "Third-generation cephalosporin-resistant enterobacterales are critical priority pathogens, too!" REPLY. Antimicrobial Agents and Chemotherapy, 66 (4), p. e00223-22. ISSN 0066-4804.
    Identifiant IRD :  PAR00024290

  5. Kochhar S., Barreira D., Beattie P., Cavaleri M., Cravioto A., Frick M. W., Ginsberg A. M., Hudson I., Kaslow D. C., Kurtz S., Lienhardt Christian, Madhi S. A., Morgan C., Momeni Y., Patel D., Rees H., Rogalski-Salter T., Schmidt A., Semete-Makokotlela B., Voss G., White R. G., Zignol M., Giersing B. (2022). Building the concept for WHO Evidence Considerations for Vaccine Policy (ECVP) : tuberculosis vaccines intended for adults and adolescents as a test case. Vaccine, 40 (12), p. 1681-1690. ISSN 0264-410X.
    Identifiant IRD :  fdi:010084539

  6. Butler M. S., Gigante V., Sati H., Paulin S., Al-Sulaiman L., Rex J. H., Fernandes P., Arias C. A., Paul M., Thwaites G. E., Czaplewski L., Alm R. A., Lienhardt Christian, Spigelman M., Silver L. L., Ohmagari N., Kozlov R., Harbarth S., Beyer P. (2022). Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections : despite progress, more action is needed. Antimicrobial Agents and Chemotherapy, 66 (3), p. e01991-21 [20 p.]. ISSN 0066-4804.
    Identifiant IRD :  fdi:010084620

2021

Articles référencés dans le Web of Science


  1. Ducrot C., Hobeika A., Lienhardt Christian, Wieland B., Dehays C., Delabouglise A., Bordier M., Goutard F., Patel E., Figuie M., Peyre M., Moodley A., Roger F. (2021). Antimicrobial resistance in Africa : how to relieve the burden on family farmers. Emerging Infectious Diseases, 27 (10), p. 2515-2520. ISSN 1080-6040.
    Identifiant IRD :  fdi:010083307

  2. Roelens M., Migliori G. B., Rozanova L., Estill J., Campbell J. R., Cegielski J. P., Tiberi S., Palmero D., Fox G. J., Guglielmetti L., Sotgiu G., Brust J. C. M., Bang D. D., Lienhardt Christian, Lange C., Menzies D., Keiser O., Raviglione M. (2021). Evidence-based definition for extensively drug-resistant tuberculosis. American Journal of Respiratory and Critical Care Medicine, 204 (6), p. 713-722. ISSN 1073-449X.
    Identifiant IRD :  PAR00023381

  3. Hills N. K., Lyimo J., Nahid P., Savic R. M., Lienhardt Christian, Phillips P. P. J. (2021). A systematic review of endpoint definitions in late phase pulmonary tuberculosis therapeutic trials. Trials, 22 (1), p. 515 [18 p.].
    Identifiant IRD :  fdi:010082682

2020

Articles référencés dans le Web of Science


  1. Lienhardt Christian, Nunn A., Chaisson R., Vernon A. A., Zignol M., Nahid P., Delaporte E., Kasaeva T. (2020). Advances in clinical trial design : weaving tomorrow's TB treatments. PLoS Medicine, 17 (2), art. e1003059 [12 p.]. ISSN 1549-1277.
    Identifiant IRD :  fdi:010079481

  2. Lienhardt Christian, Raviglione M. C. (2020). TB elimination requires discovery and development of transformational agents. Applied Sciences-Basel, 10 (7), p. art. 2605 [5 p.].
    Identifiant IRD :  fdi:010078216

  3. Jouvin-Marche E., Carrara G., Pulcini C., Andremont A., Danan C., Couderc-Obert C., Lienhardt Christian, Kieny M. P., Yazdanpanah Y. (2020). French research strategy to tackle antimicrobial resistance. Lancet, 395 (10232), p. 1239-1241. ISSN 0140-6736.
    Identifiant IRD :  fdi:010078996

2019

Articles référencés dans le Web of Science


  1. Lienhardt Christian, Vernon A. A., Cavaleri M., Nambiar S., Nahid P. (2019). Development of new TB regimens : harmonizing trial design, product registration requirements, and public health guidance. PLoS Medicine, 16 (9), p. e1002915 [13 p.]. ISSN 1549-1277.
    Identifiant IRD :  fdi:010077108

  2. Pontali E., Raviglione M. C., Migliori G. B., Akkerman O. W., Alffenaar J. W., Blanc F. X., Borisov S., Cirillo D. M., Dalcolmo M., Dheda K., Kritski A. L., Lienhardt Christian, Olliaro P., Tadolini M., Tiberi S., Udwadia Z., Global T. B. Network Clinical Trials. (2019). Regimens to treat multidrug-resistant tuberculosis : past, present and future perspectives. European Respiratory Review, 28 (152), p. art. 190035 [7 p.]. ISSN 0905-9180.
    Identifiant IRD :  fdi:010076505

  3. Gomes M. G. M., Oliveira J. F., Bertolde A., Ayabina D., Nguyen T. A., Maciel E. L., Duarte R., Nguyen B. H., Shete P. B., Lienhardt Christian. (2019). Introducing risk inequality metrics in tuberculosis policy development. Nature Communications, 10, p. art. 2480 [12 p.]. ISSN 2041-1723.
    Identifiant IRD :  fdi:010076067

  4. Phillips P. P. J., Mitnick C. D., Neaton J. D., Nahid P., Lienhardt Christian, Nunn A. J. (2019). Keeping phase III tuberculosis trials relevant : adapting to a rapidly changing landscape. PLoS Medicine, 16 (3), p. e1002767 [15 p.]. ISSN 1549-1277.
    Identifiant IRD :  fdi:010075590

  5. Lienhardt Christian, Nahid P. (2019). Advances in clinical trial design for development of new TB treatments : a call for innovation. PLoS Medicine, 16 (3), p. e1002769 [5 p.]. ISSN 1549-1277.
    Identifiant IRD :  fdi:010075589

  6. Reis-Santos B., Shete P., Bertolde A., Sales C. M., Sanchez M. N., Arakaki-Sanchez D., Andrade K. B., Gomes M. G. M., Boccia D., Lienhardt Christian, Maciel E. L. (2019). Tuberculosis in Brazil and cash transfer programs : a longitudinal database study of the effect of cash transfer on cure rates. PLoS One, 14 (2), p. e0212617 [18 p.]. ISSN 1932-6203.
    Identifiant IRD :  fdi:010075281

  7. Oliosi J. G. N., Reis-Santos B., Locatelli R. L., Sales C. M. M., Filho W. G. D., da Silva K. C., Sanchez M. N., Andrade K. V. F., Shete P. B., Pereira S. M., Riley L. W., Lienhardt Christian, Maciel E. L. N., De Araojo G. S. (2019). Effect of the Bolsa Familia Programme on the outcome of tuberculosis treatment : a prospective cohort study. Lancet Global Health, 7 (2), p. E219-E226. ISSN 2214-109X.
    Identifiant IRD :  fdi:010074944

  8. Theuretzbacher U., Gottwalt S., Beyer P., Butler M., Czaplewski L., Lienhardt Christian, Moja L., Paul M., Paulin S., Rex J. H., Silver L. L., Spigelman M., Thwaites G. E., Paccaud J. P., Harbarth S. (2019). Analysis of the clinical antibacterial and antituberculosis pipeline. Lancet Infectious Diseases, 19 (2), p. E40-E50. ISSN 1473-3099.
    Identifiant IRD :  fdi:010075145

2018

Articles référencés dans le Web of Science


  1. Kik S. V., Schumacher S., Cirillo D. M., Churchyard G., Boehme C., Goletti D., Rangaka M. X., Denkinger C. M., Lienhardt Christian, Gilpin C., Matteelli A., Cobelens F. (2018). An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. European Respiratory Journal, 52 (4), p. art. 1800946 [9 p.]. ISSN 0903-1936.
    Identifiant IRD :  fdi:010074800

  2. Imperial M. Z., Nahid P., Phillips P. P. J., Davies G. R., Fielding K., Hanna D., Hermann D., Wallis R. S., Johnson J. L., Lienhardt Christian, Savic R. M. (2018). A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosis. Nature Medicine, 24 (11), p. 1708-1715 + 4p. ISSN 1078-8956.
    Identifiant IRD :  fdi:010074387

  3. Shete P.B., Boccia D., Dhavan P., Gebreselassie N., Lönnroth K., Marks S., Matteelli A., Posey D.L., Van der Werf M.J., Winston C.A., Lienhardt Christian. (2018). Defining a migrant-inclusive tuberculosis research agenda to end TB [+ Erratum IJTLD.2018, vol. 22, no 10, p. 1244]. International Journal of Tuberculosis and Lung Disease, 22 (8), p. 835-843 [+ Erratum IJTLD.2018, vol. 22, no 10, p. 1244]. ISSN 1027-3719.
    Identifiant IRD :  fdi:010073876

  4. Kendall E. A., Brigden G., Lienhardt Christian, Dowdy D. W. (2018). Would pan-tuberculosis treatment regimens be cost-effective ?. Lancet Respiratory Medicine, 6 (7), p. 486-488. ISSN 2213-2600.
    Identifiant IRD :  fdi:010073637

2017

Articles référencés dans le Web of Science


  1. Olliaro P. L., Merle C., Mthiyane T., Bah B., Kassa F., Amukoye E., N'Diaye A., Perronne C., Lienhardt Christian, McIlleron H., Fielding K. (2017). Effects on the QT interval of a gatifloxacin-containing regimen versus standard treatment of pulmonary tuberculosis. Antimicrobial Agents and Chemotherapy, 61 (7), p. e01834-16 [11 p.]. ISSN 0066-4804.
    Identifiant IRD :  fdi:010070864

2014

Articles référencés dans le Web of Science


  1. Merle C.S., Fielding K., Bah Sow O., Gnignafon M., Lo M.B., Mthiyane T., Odhiambo J., Amukoye E., Bah B., Kassa F., N'Diaye A., Rustomjee R., De Jong B.C., Horton J., Perronne C., Sismanidis C., Lapujade O., Olliaro P.L., Lienhardt Christian. (2014). A four-month gatifloxacin-containing regimen for treating tuberculosis. New England Journal of Medicine, 371 (17), p. 1588-1598. ISSN 0028-4793.
    Identifiant IRD :  fdi:010063069

2013

Articles référencés dans le Web of Science


  1. Smythe W., Merle C. S., Rustomjee R., Gninafon M., Lo M. B., Bah-Sow O., Olliaro P. L., Lienhardt Christian, Horton J., Smith P., McIlleron H., Simonsson U. S. H. (2013). Evaluation of initial and steady-state gatifloxacin pharmacokinetics and dose in pulmonary tuberculosis patients by using Monte Carlo simulations. Antimicrobial Agents and Chemotherapy, 57 (9), p. 4164-4171. ISSN 0066-4804.
    Identifiant IRD :  PAR00010835

2012

Articles référencés dans le Web of Science


  1. Lienhardt Christian, Raviglione M., Spigelman M., Hafner R., Jaramillo E., Hoelscher M., Zumla A., Gheuens J. (2012). New drugs for the treatment of tuberculosis : needs, challenges, promise, and prospects for the future. Journal of Infectious Diseases, 205 (suppl. 2), p. S241-S249. ISSN 0022-1899.
    Identifiant IRD :  fdi:010059621

  2. Lienhardt Christian, Raviglione M., Spigelman M., Hafner R., Jaramillo E., Hoelscher M., Zumla A., Gheuens J. (2012). Errata : new drugs for the treatment of tuberculosis : needs, challenges, promise, and prospects for the future (Journal of Infectious Deseases, vol. 205, p. S241-S249, 2012). Journal of Infectious Diseases, 206 (7), p. 1152. ISSN 0022-1899.
    Identifiant IRD :  fdi:010059622

  3. Smythe W., Khandelwal A., Merle C., Rustomjee R., Gninafon M., Lo M. B., Sow O. B., Olliaro P. L., Lienhardt Christian, Horton J., Smith P., McIlleron H., Simonsson U. S. H. (2012). A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients. Antimicrobial Agents and Chemotherapy, 56 (4), p. 2091-2098. ISSN 0066-4804.
    Identifiant IRD :  PAR00008782

2011

Chapitres ou parties d'ouvrages


  1. Lienhardt Christian. (2011). La tuberculose dans le monde aujourd'hui : enjeux, recherche et perspectives. In : Kereoudan D. (dir.). Santé internationale : les enjeux de santé au Sud. Paris : Presses de Sciences Po, p. 59-74. (Santé). ISBN 978-2-7246-1172-4.
    Identifiant IRD :  fdi:010051833

2010

Articles référencés dans le Web of Science


  1. Khor C. C., Vannberg F. O., Chapman S. J., Guo H. Y., Wong S. H., Walley A. J., Vukcevic D., Rautanen A., Mills T. C., Chang K. C., Kam K. M., Crampin A. C., Ngwira B., Leung C. C., Tam C. M., Chan C. Y., Sung J. J. Y., Yew W. W., Toh K. Y., Tay S. K. H., Kwiatkowski D., Lienhardt Christian, Hien T. T., Day N. P., Peshu N., Marsh K., Maitland K., Scott J. A., Williams T. N., Berkley J. A., Floyd S., Tang N. L. S., Fine P. E. M., Goh D. L. M., Hill A. V. S. (2010). CISH and susceptibility to infectious diseases. New England Journal of Medicine, 362 (22), p. 2092-2101. ISSN 0028-4793.
    Identifiant IRD :  PAR00005833

  2. Lienhardt Christian, Fielding K., Hane A. A., Niang A., Ndao Cheikh, Karam F., Fletcher H., Mbow Fatou, Gomis Jules-François, Diadhiou R., Toupane M., Dieye T., Mboup S. (2010). Evaluation of the prognostic value of IFN-gamma release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. Plos One, 5 (5), p. e10508. ISSN 1932-6203.
    Identifiant IRD :  fdi:010049510

2009

Articles référencés dans le Web of Science


  1. Menzies D., Benedetti A., Paydar A., Royce S., Pai M., Burman W., Vernon A., Lienhardt Christian. (2009). Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid : a systematic review and meta-analysis. Plos Medicine, 6 (9), p. e1000150. ISSN 1549-1277.
    Identifiant IRD :  fdi:010048337

  2. Menzies D., Benedetti A., Paydar A., Martin I., Royce S., Pai M., Vernon A., Lienhardt Christian, Burman W. (2009). Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes : a systematic review and meta-analysis. Plos Medicine, 6 (9), p. e1000146. ISSN 1549-1277.
    Identifiant IRD :  fdi:010048336

2008

Articles référencés dans le Web of Science


  1. Vannberg F. O., Chapman S. J., Khor C. C., Tosh K., Floyd S., Jackson-Sillah D., Crampin A., Sichali L., Bah B., Gustafson P., Aaby P., McAdam Kpwj, Bah-Sow O., Lienhardt Christian, Sirugo G., Fine P., Hill A. V. S. (2008). CD209 genetic polymorphism and tuberculosis disease. PLoS One, 3 (1), art. no e1388 [6 p.]. ISSN 1932-6203.
    Identifiant IRD :  fdi:010071437

  2. Karam F., Mbow F., Fletcher H., Senghor C. S., Coulibaly K. D., LeFevre A. M., Gueye N. F. N., Dieye T., Sow P. S., Mboup S., Lienhardt Christian. (2008). Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. Plos One, 3 (1), p. e1441. ISSN 1932-6203.
    Identifiant IRD :  fdi:010048494

  3. Rustomjee R., Lienhardt Christian, Kanyok T., Davies G. R., Levin J., Mthiyane T., Reddy C., Sturm A. W., Sirgel F. A., Allen J., Coleman D. J., Fourie B., Mitchison D. A. (2008). A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. International Journal of Tuberculosis and Lung Disease, 12 (2), p. 128-138. ISSN 1027-3719.
    Identifiant IRD :  PAR00002155

2007

Articles référencés dans le Web of Science


  1. Thiam Sylla, Lefevre A. M., Hane Fatoumata, Ndiaye Alimatou, Ba F, Fielding K.L., Ndir M., Lienhardt Christian. (2007). Effectiveness of a strategy to improve adherence to tuberculosis treatment in resource poor setting : a cluster randomized controlled trial. Journal of American Medical Association, 297 (4), p. 380-386. ISSN 1538-3598.
    Identifiant IRD :  fdi:010039952

  2. Khor C. C., Chapman S. J., Vannberg F. O., Dunne A., Murphy C., Ling E. Y., Frodsham A. J., Walley A. J., Kyrieleis O., Khan A., Aucan C., Segal S., Moore C. E., Knox K., Campbell S. J., Lienhardt Christian, Scott A., Aaby P., Sow O. Y., Grignani R. T., Sillah J., Sirugo G., Peshu N., Williams T. N., Maitland K., Davies R. J. O., Kwiatkowski D. P., Day N. P., Yala D., Crook D. W., Marsh K., Berkley J. A., O' Neill L.A.J., Hill A. V. S. (2007). A mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nature Genetics, 39 (4), p. 523-528. ISSN 1061-4036.
    Identifiant IRD :  fdi:010069206

  3. Gustafson P., Lisse I., Gomes V., Vieira C. S., Lienhardt Christian, Naucler A., Jensen H., Aaby P. (2007). Risk factors for positive tuberculin skin test in Guinea-Bissau. Epidemiology, 18 (3), p. 340-347. ISSN 1044-3983.
    Identifiant IRD :  PAR00001609

  4. Hane Fatoumata, Thiam Sylla, Fall A. S., Vidal Laurent, Diop A. H., Ndir M., Lienhardt Christian. (2007). Identifying barriers to effective tuberculosis control in Senegal : an anthropological approach. International Journal of Tuberculosis and Lung Disease, 11 (5), p. 539-543. ISSN 1027-3719.
    Identifiant IRD :  PAR00001650

  5. Jackson Sillah D., Hill P. C., Fox A., Brookes R. H., Donkor S. A., Lugos M. D., Howie S. R. C., Fielding K. R., Jallow A., Lienhardt Christian, Corrah T., Adegbola R. A., McAdam K. P. (2007). Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia. Transactions of the Royal Society of Tropical Medicine and Hygiene, 101 (6), p. 594-601. ISSN 0035-9203.
    Identifiant IRD :  fdi:010040602

2006

Articles référencés dans le Web of Science


  1. Lienhardt Christian, Rustomjee R. (2006). Improving tuberculosis control : an interdisciplinary approach. Lancet, 367 (9514), p. 949-950. ISSN 0140-6736.
    Identifiant IRD :  fdi:010035581

  2. Tosh K., Campbell S.J., Fielding K., Sillah J., Bah B., Gustafson P., Manneh K., Lisse I., Sirugo G., Bennett S., Aaby P., McAdam K., Bah Sow O., Lienhardt Christian, Kramnik I., Hill A.V.S. (2006). Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proceedings of the National Academy of Sciences of the United States of America, 103 (27), p. 10364-10368. ISSN 0027-8424.
    Identifiant IRD :  fdi:010035710

  3. Cooke G. S., Campbell S. J., Sillah J., Gustafson P., Bah B., Sirugo G., Bennett S., McAdam Kpwj, Sow O., Lienhardt Christian, Hill A. V. S. (2006). Polymorphism within the Interferon-gamma/Receptor complex is associated with pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine, 174 (3), p. 339-343. ISSN 1073-449X.
    Identifiant IRD :  fdi:010056616

  4. Hill P.C., Jackson Sillah D., Donkor S.A., Otu J., Adegbola R.A., Lienhardt Christian. (2006). Risk factors for pulmonary tuberculosis : a clinic-based case control study in the Gambia. Bmc Public Health, 6, p. art. no. 156 - NIL_1-NIL_7. ISSN 1471-2458.
    Identifiant IRD :  fdi:010035751

  5. Ibango H.B., Brookes R.H., Hill P.C., Owiafe P.K., Fletcher H.A., Lienhardt Christian, Hill A.V.S., Adegbola R. A., McShane H. (2006). Early clinical trials with a new tuberculosis vaccine, MVA85A, in tuberculosis-endemic countries : issues in study design. Lancet Infectious Diseases, 6 (8), p. 522-528. ISSN 1473-3099.
    Identifiant IRD :  fdi:010035752

2005

Articles référencés dans le Web of Science


  1. Lienhardt Christian, Zumla A. (2005). BCG : the story continues. Lancet, 366 (9495), p. 1414-1416. ISSN 0140-6736.
    Identifiant IRD :  fdi:010036702

  2. Lienhardt C., Cook S. V. (2005). Conducting clinical trials on tuberculosis in resource-poor countries: imposed science or equally-shared efforts?. International Journal of Tuberculosis and Lung Disease, 9 (9), p. 943. ISSN 1027-3719.
    Identifiant IRD :  PAR00000458

  3. Greenaway C., Lienhardt C., Adegbola R., Brusasca R., McAdam K., Menzies D. (2005). Humoral response to Mycobacterium tuberculosis antigens in patients with tuberculosis in the Gambia. International Journal of Tuberculosis and Lung Disease, 9 (10), p. 1112-1119. ISSN 1027-3719.
    Identifiant IRD :  PAR00000506

  4. Hill R. C., Stevens W., Hill S., Bah J., Donkor S. A., Jallow A., Lienhardt C.. (2005). Risk factors for defaulting from tuberculosis treatment: a prospective cohort study of 301 cases in The Gambia. International Journal of Tuberculosis and Lung Disease, 9 (12), p. 1349-1354. ISSN 1027-3719.
    Identifiant IRD :  PAR00000709

2001

Articles


  1. Lienhardt Christian. (2001). From exposure to disease : the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiologic Reviews, 23 (2), p. 288-299. ISSN 0193-963X.
    Identifiant IRD :  fdi:010030031

  2. Marchant A., Amedei A., Azzurri A., Vekemans J., Benagiano M., Tamburini C., Lienhardt Christian, Corrah T., McAdam K.P.W.J., Romagnani S., D'Elios M.M., Del Prete G. (2001). Polarization of PPD-Specific T-Cell response of patients with tuberculosis from Th0 to Th1 profile after successful antimycobacterial therapy or in vitro conditioning with interferon-alpha or interleukin-12. American Journal of Respiratory Cell and Molecular Biology, 24 (2), p. 187-194. ISSN 1044-1549.
    Identifiant IRD :  fdi:010030032

  3. Lienhardt Christian, Rowley J., Manneh K., Lahai G., Needham D, Milligan P., McAdam K.P.W.J. (2001). Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country : the experience of the Gambia. International Journal of Tuberculosis and Lung Disease, 5 (3), p. 233-239. ISSN 1027-3719.
    Identifiant IRD :  fdi:010030033

  4. Vekemans J., Lienhardt Christian, Sillah J.S., Wheeler J.G., Lahal G.P., Doherty M.T., Corrah T., Andersen P., McAdam K.P.W.J., Marchant A. (2001). Tuberculosis contacts but no patients have higher Gamma interferon responses to ESAT-6 than do community controls in the Gambia. Infection and Immunity, 69 (10), p. 6554-6557. ISSN 0019-9567.
    Identifiant IRD :  fdi:010030034
Contact